Clin2
NCT07608627Possibly a fitNot yet recruiting

PET scan imaging for pancreatic cancer

Locally Advanced Pancreatic AdenocarcinomaMetastatic Pancreatic AdenocarcinomaStage III Pancreatic Cancer AJCC v8Stage IV Pancreatic Cancer AJCC v8

Part of Cancer, Digestive system, Hormones & metabolism clinical trials.

This trial uses a new imaging agent called 64Cu-DOTA A2 to help see pancreatic cancer on a PET scan. It may help doctors find cancer that has spread, without the need for surgery.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
15 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You have been diagnosed with pancreatic cancer that has spread or cannot be removed by surgery.
  • Your doctor has confirmed the cancer on a recent scan (within the last 8 weeks).
  • You have not had radiation treatment to the tumor.
  • Your liver and kidney function tests are within acceptable ranges.
  • You are able to take care of yourself (more than 70% on the Karnofsky scale).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07217717Recruiting· Phase 3
New PET scan for pancreatic cancer staging

This study tests a new type of PET scan that uses a radioactive tracer called FAPI-74 to find cancer spread in people with pancreatic cancer. The goal is to see if this scan can help doctors better plan treatment.

Cerritos, California
NCT05518903Recruiting· Phase 2
Scan test to see tumor-support cells in pancreatic cancer

This trial tests a special imaging scan (a PET/CT with a tracer called 68Ga-FAPI-46) to look at “cancer-support” cells in people with localized pancreatic ductal adenocarcinoma. It may help doctors better understand the tumor and how it responds before surgery after initial treatment.

Rochester, Minnesota
NCT06659705Recruiting· Phase 2
New PET scan for early pancreatic cancer detection

This trial tests a new type of PET scan that uses a special tracer (FAPI) to get clearer images of pancreatic cancer. The goal is to find cancer earlier and better plan surgery or treatment.

Saint-Cloud
NCT06601010Recruiting
PET scan to monitor immunotherapy in pancreatic cancer

This trial uses a special PET scan (68Ga-grazytracer) to see how well immunotherapy is working for pancreatic cancer. It may help your doctor understand if your treatment is effective.

Shanghai, Shanghai Municipality
NCT06911021Not yet recruiting
New imaging scan for pancreatic cancer before surgery

This study tests a new imaging agent (68Ga-FAPI-46) to see if it can better show the extent of pancreatic cancer before surgery. It may help doctors plan your surgery more accurately.

Lausanne, Canton of Vaud
NCT07629609Recruiting· Phase 2
New PET scan imaging for pancreatic and stomach cancers

This study tests a new type of PET scan (a detailed imaging test) called [68Ga]Ga-FAPI that may help doctors see cancer better and faster than standard scans. You'll receive this experimental scan to see if it improves cancer detection before surgery.

Copenhagen

Hear when a new Locally Advanced Pancreatic Adenocarcinoma trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.